Results 11 to 20 of about 207,426 (323)

Interleukin-6 receptor blockade suppresses subretinal fibrosis in a mouse model [PDF]

open access: yesInternational Journal of Ophthalmology, 2014
AIM:To determine the involvement of the interleukin (IL)-6 with the development of experimental subretinal fibrosis in a mouse model.METHODS:Subretinal fibrosis was induced by subretinal injection of macrophage-rich peritoneal exudate cells and the local
Wei Cui, Han Zhang, Zhe-Li Liu
doaj   +1 more source

Age-Related Macular or Retinal Degeneration?

open access: yesMedicina, 2023
Age-related macular degeneration (AMD) is an eye disease that leads to progressive vision loss. Its prevalence has been increasing due to population aging.
Michalina Gałuszka   +2 more
doaj   +1 more source

Age-related macular degeneration: an overview

open access: yesRevista Brasileira de Oftalmologia, 2021
Age-related macular degeneration is the most important cause of irreversible vision loss in the elderly and has been considered a severe public health problem. Current treatments have only been successful in delaying the loss of central vision.
Rogil José de Almeida Torres   +1 more
doaj   +1 more source

Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration

open access: yesJAMA ophthalmology, 2023
This randomized clinical trial assesses the safety and efficacy of aflibercept, 8 mg, in patients with neovascular age-related macular degeneration.
C. Wykoff   +76 more
semanticscholar   +1 more source

Oxidative Stress and Antioxidants in Age-Related Macular Degeneration

open access: yesAntioxidants, 2023
Oxidative stress plays a crucial role in aging-related eye diseases, including age-related macular degeneration (AMD), cataracts, and glaucoma. With age, antioxidant reparative capacity decreases, and excess levels of reactive oxygen species produce ...
N. Kushwah   +4 more
semanticscholar   +1 more source

Nanotechnology for Age-Related Macular Degeneration

open access: yesPharmaceutics, 2021
Age-related macular degeneration (AMD) is a degenerative eye disease that is the leading cause of irreversible vision loss in people 50 years and older.
Bo Yang   +6 more
doaj   +1 more source

Complement C3 variant and the risk of age-related macular degeneration [PDF]

open access: yes, 2007
Background: Age-related macular degeneration is the most common cause of blindness in Western populations. Susceptibility is influenced by age and by genetic and environmental factors.
Armbrecht, AM   +16 more
core   +1 more source

Y chromosome mosaicism is associated with age-related macular degeneration [PDF]

open access: yes, 2019
Acknowledgements The authors thank Sudha K. Iyengar, Rob Igo and Alberto H. Santana (Case Western Reserve University, Cleveland, Ohio, USA) as well as the IAMDGC (http://eaglep.case.edu/iamdgc_web/) for providing the raw probe intensities.
on behalf of the International Age-related Macular Degeneration Genomics Consortium (IAMDGC)
core   +1 more source

Prevalence of Age-Related Macular Degeneration in the US in 2019.

open access: yesJAMA ophthalmology, 2022
Importance Age-related macular degeneration (AMD) is a leading cause of vision loss and blindness. AMD prevalence has not been estimated for the US in over a decade and early-stage AMD prevalence estimates are scarce and inconsistently measured ...
David B. Rein   +7 more
semanticscholar   +1 more source

Macular Pigment Optical Density and its Determinants among Adults: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: Interplay exists between the risk factors of Agerelated Macular Degeneration (AMD) and the factors influencing Macular Pigment Optical Density (MPOD) level.
POOJA GOYAL   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy